Philip M. Bauer

University of Louisville — United States

Medicine · Health Sciences

32h-index3.4kcitations61works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nitric Oxide and Endothelin Effects(14), Pulmonary Hypertension Research and Treatments(14), Caveolin-1 and cellular processes(8), Renin-Angiotensin System Studies(5), Liver Disease and Transplantation(4)

Publications61 total

Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration
The Journal of Pathology·2023· 15 citedOpen Access
Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis
Drug Design Development and Therapy·2022· 11 citedOpen Access
Su1692 DECREASED RHO KINASE SIGNALING AND CONTRACTILITY OF HEPATIC STELLATE CELLS BY PDE4 INHIBITOR ATTENUATES FIBROTIC PATHWAYS IN VIVO AND IN VITRO
Gastroenterology·2020
Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench
Hepatology·2019· 58 citedOpen Access
Proteomic and Phosphoproteomic Analyses Identify Novel Targets Involved in Beneficial Effect of Rolipram on Liver Fibrosis in Mice
The FASEB Journal·2019
Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism
Molecular and Cellular Neuroscience·2017· 36 citedOpen Access
Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury
The International Journal of Biochemistry & Cell Biology·2016· 233 citedOpen Access
Sa1627 Lipotherapy with Fusogenic Liposomes Protects Liver in a Model of Rat Partial Ischemia Reperfusion Injury
Gastroenterology·2016
Phosphorylation of Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) by Akt Promotes Stability and Mitogenic Function of S-phase Kinase-associated Protein-2 (Skp2)
Journal of Biological Chemistry·2014· 24 citedOpen Access
Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
PLoS ONE·2014· 19 citedOpen Access
Infusion of cardioplegia with monounsaturated lipids attenuates myocardial injury: involvement of lipid rafts in the protective effect (667.8)
The FASEB Journal·2014
Genetic Deletion of Toll-Like Receptor 4 on Platelets Attenuates Experimental Pulmonary Hypertension
Circulation Research·2014· 63 citedOpen Access
Caveolae-Dependent and -Independent Uptake of Albumin in Cultured Rodent Pulmonary Endothelial Cells
PLoS ONE·2013· 63 citedOpen Access
Abstract 13042: Ezrin Binding Phosphoprotein 50 Promotes Inflammation and Atherosclerosis
Circulation·2013
Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) and Nuclear Factor-κB (NF-κB)
Journal of Biological Chemistry·2013· 30 citedOpen Access
Successful immunotherapy with interleukin 2 for hypoxia-induced pulmonary hypertension (P3371)
The Journal of Immunology·2013
High Mobility Group Box 1 Contributes to the Pathogenesis of Experimental Pulmonary Hypertension via Activation of Toll-like Receptor 4
Molecular Medicine·2012· 97 citedOpen Access
High Mobility Group Box 1 Inhibits Human Pulmonary Artery Endothelial Cell Migration via a Toll-like Receptor 4- and Interferon Response Factor 3-dependent Mechanism(s)
Journal of Biological Chemistry·2012· 55 citedOpen Access
Stabilizing endothelium of donor hearts with fusogenic liposomes reduces myocardial injury and dysfunction
Journal of Surgical Research·2012· 4 citedOpen Access
A Novel Role For Interferon Response Factor 3 And Interferon Alpha In The Development Of Pulmonary Hypertension
2012
page 1 of 4Next →

Frequent Co-authors

Eileen Bauer(11), William C. Sessa(8), Claudio Maldonado(8), Louis J. Ignarro(5), Georgette M. Buga(5), Craig J. McClain(5), Mepur H. Ravindranath(5), Pascal Bernatchez(4), Han Zheng(4), Timothy R. Billiar(4), Walter Rodríguez(4), Leila Gobejishvili(4), Amir A. Amiri(4), Donald L. Morton(4), Brian S. Zuckerbraun(3), Jun Yu(3), Jon M. Fukuto(3), Suzy Comhair(3), Serpil C. Erzurum(3), Jeffrey W. Wertz(3)